First National Daily eMedical News Paper of India
Nobody Reports News Better Than Us  
Editorial (Dr SS Agarwal, Dr K K Aggarwal)
10th April 2016
IMA-PvPI Pharmacovigilance Initiative 
Dear Colleague
As you may be well aware, efficacy and safety of a new drug are generally studied on only a few thousand trial subjects and patients. For this reason, only frequent adverse reactions can be observed during its clinical development.
Once the product has been placed on the market, a much larger, and also often polymorbid population will be exposed, which may lead to a change in the drug's hitherto known safety profile. Adverse drug reactions can then be observed more frequently, including those occurring only sporadically and independently of the pharmacological properties of the substance.

These new adverse reactions, should be reported without delay as a contribution to a potentially still incomplete safety profile. If such information is consistently forwarded to the competent authorities, hitherto unknown risks can be identified and tackled.

Under the IMA-PvPI initiative, Indian Medical Association (IMA) has become a nodal centre for reporting of Adverse Drug Reactions (ADR) / Adverse Events (AE) under the Pharmaco Vigilance Programme of India (PvPI).

IMA is compiling the data of ADR / AE related to drugs/ vaccines/ medical devices/ blood products & Herbals. One can contact IMA-PvPI ADR/AE helpline and report any ADR/AE to Ms. Megha Joshi on Mobile No. +919717776514 from Monday till Friday from 9am to 5pm.
To Read More or Comment, Click Here
Top News
Practice Updates

Journal of the American Heart Association Update: Good heart health may prevent CKD

International Stroke Conference Update: tPA clot thrombolysis may benefit intraventricular hemorrhage
Systemic Sclerosis World Congress Update: Risk factors for digital ulcers in systemic sclerosis
eMedi Humor
Medicolegal Corner
eMedi Quiz
Photo Quiz
Ask the Specialist Videos
Lifestyle Updates
eMediNexus Specialty Weekly Newsletters
Second Opinion Required
Press Release
Padma Awardee Doctors Forum Supports the 85% pictorial warning on tobacco products
New Delhi, April 9, 2016: The Padma Awardee Doctors Forum has written to the Prime Minister regarding the on-going plea for 85% pictorial warning on all tobacco products.
A notification by the Health Ministry on September 24, 2015, for implementation of the Cigarettes and other Tobacco Products (Packaging and Labeling) Amendment Rules, 2014, came into force on April 1, 2016. These prescribe larger pictorial warnings, covering 85 per cent of packets on tobacco products.
The IMA in the recent past mobilised lakhs of Indian doctors across India, developed a white paper on the urgent need of large Pictorial health warnings and called upon the President, Prime Minister, Vice President, Health Minister and the Finance Minister to implement the 85% warnings An SMS campaign was launched on the health effects of tobacco by IMA. 
To Read More or Comment, Click Here
Yoga for Health
Yoga and postmenopausal women
In clinically healthy postmenopausal women, practice of yoga can affect the female neuroendocrine systemRead more
IMA Updates
Lybrate Question of the Day
Can endometriosis cause heart disease?
Lybrate SMS of the Day
Friends are the siblings God never gave us. Mencius

Awareness on Organ Donation​
IMA TB Initiative 
IMA Starts Nodal center for adverse drug reactions

IMA PvPI Initiative has started a nodal center at IMA headquarters. All IMA members can now report adverse reactions to drugs, vaccines, medical devices, Blood products and herbal products at IMA PvPI helpline 9717776514, open Monday to Friday 9-5.30PM
IMA Polio Dates
  • April 11th: bOPV would be available in private market but it is not to be opened or used before 25th April.
  • April 25: IMA Polio Switch Day, when tOPV would be completely withdrawn and replaced by bOPV in both routine immunization and polio campaigns.
  • 9th May: IMA National Validation Day when India would be declared free of tOPV. 

IMA Satyagraha -

Dr Good Dr Bad And Make Sure
eIMA News Update
Digital IMA
The Indian Medical Association (IMA) presents a series of weekly webcasts for the benefit of the Indian medical profession, engaging you with the latest in advocacy efforts for doctors, through an interactive exclusive digital webcast partnership with eMediNexus.

Webcast Date: 14th April 2016